GSK will focus on prescription drugs and vaccines while Haleon will focus on consumer health, selling products from brands such as Sensodyne toothpaste and Advil painkillers. The company already has two deals in the works to switch some prescription only medicines to over the counter.
“Its big-brand pulling power should help it hang onto customers, who may trade down other products in shopping baskets instead,” Susannah Streeter, senior analyst at Hargreaves Lansdown told Bloomberg.
At Becker's 4th Annual CEO + CFO Roundtable, taking place November 2–5 in Chicago, more than 1,500 hospital and health system executives tackle decisions that determine whether organizations thrive or merely survive: protecting margins under cost pressure, choosing where to grow, renegotiating payer relationships, stabilizing the workforce and proving real ROI on technology. This is where leaders work through them together, face-to-face. Apply for complimentary registration now.
